TotalFinaElf announces the sale of 2.3% of the share capital of Sanofi-Synthélabo, or 16.7 million shares held by Elf Aquitaine, to be placed with institutional investors.
This sale is in line with the strategy announced by the Group.
Elf Aquitaine's 32.7% ownership of the share capital of Sanofi-Synthélabo before this transaction is reduced to 30.4% following the sale.
Following the public exchange offer for Elf Aquitaine which closed on September 1, 2000, TotalFinaElf owns 99.5% of Elf Aquitaine. |
